Insulet to Report Third Quarter 2021 Financial Results on November 4, 2021


ACTON, Mass .– (COMMERCIAL THREAD) – Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the world leader in tubeless insulin pump technology with its Omnipod® product brand, today announced its intention to release its financial results for the third quarter of 2021 on November 4, 2021 after the close of financial markets. As part of the outing, management will host a conference call that day at 4:30 p.m. EST.

The link to the live call will be available in the Investor Relations section of the Company’s website at Investors.insulet.com, “Events and Presentations”, and will be archived for a future replay. To participate in the live call by phone, please pre-register online here. You will then receive a phone number and password required to enter the call.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making life easier for people with diabetes and other conditions through its platform of products Omnipod. The Omnipod Insulin Management System offers a unique alternative to traditional methods of insulin delivery. With its simple and portable design, the Disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also takes advantage of its unique Pod design by adapting its Omnipod technology platform for subcutaneous drug delivery without insulin in other therapeutic areas. For more information, please visit: insulet.com and omnipod.com.

Previous A financial expert appointed chairman of the Accounting and Finance department of Collat ​​- News
Next NYT's ignorant attempt to write Empire State Building obituary